Warning letterPosted September 22, 2026
FDA warning letter to Advance-Esthetic LLC
Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device
FDA posted a warning letter to Advance-Esthetic LLC on September 22, 2026; the letter is dated August 25, 2026. Subject: Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device. Issuing office: Center for Devices and Radiological Health.
On the record
- Company
- Advance-Esthetic LLC
- Subject
- Investigational Device Exemptions (IDE)/Premarket Approval Application (PMA) Adulterated Device
- Issuing office
- Center for Devices and Radiological Health
- Letter dated
- 2026-08-25
- Posted by FDA
- 2026-09-22
- Source
- FDA warning letters ↗
CFR cited
The record cites 3 sections of 21 CFR Parts 807 and 890.
The full record
An account shows the violations FDA described and each CFR section it cited.
What a warning letter is
A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.
More
Watch Advance-Esthetic LLC
A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.
From FDA warning letters. The record may have changed since it was read.
Approve Suite is not affiliated with FDA, or with Advance-Esthetic LLC.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.